Natural Alternatives International (NAII)
Manufactures private-label supplements and licenses beta-alanine ingredients.
$1.89
After hours0.00 (0.00%)
At close$1.89(+1.07%)
In millions of USD, except per-share figures
| In millions | Q4 FY22Jun 2023 | Q1 FY23Sep 2023 | Q2 FY23Dec 2023 | Q3 FY23Mar 2024 | Q4 FY23Jun 2024 | Q1 FY24Sep 2024 | Q2 FY24Dec 2024 | Q3 FY24Mar 2025 | Q4 FY24Jun 2025 | Q1 FY25Sep 2025 | Q2 FY25Dec 2025 | Q3 FY25Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36 | 34 | 25 | 25 | 29 | 33 | 34 | 29 | 34 | 37 | 35 | 35 |
| Cost of revenue | 31 | 31 | 25 | 23 | 28 | 31 | 32 | 27 | 30 | 33 | 32 | 35 |
| Gross profit | 5 | 3 | 0 | 2 | 1 | 2 | 2 | 2 | 4 | 4 | 2 | 0 |
| 2 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | |
| Research & development | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 |
| 2 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |
| Selling & marketing | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 1 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 4 | 4 | 0 | 0 |
| Other expenses | −2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −2 | 0 | 0 |
| Operating income | 3 | −1 | −4 | −2 | −3 | −2 | −3 | −2 | −2 | 0 | −2 | −4 |
| 0 | 0 | 0 | 0 | 0 | −1 | 0 | −1 | −1 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 0 |
| Income before tax | 3 | −1 | −4 | −2 | −3 | −2 | −3 | −3 | −3 | 0 | −2 | −4 |
| Income tax expense | 1 | 0 | −1 | 0 | −1 | 0 | −1 | 0 | 4 | 0 | 0 | 0 |
| Net income from continuing operations | 2 | −1 | −3 | −2 | −2 | −2 | −2 | −2 | −7 | 0 | −3 | −4 |
| Net income | 2 | −1 | −3 | −2 | −2 | −2 | −2 | −2 | −7 | 0 | −3 | −4 |
| EPS, basic | $0.35 | −$0.12 | −$0.52 | −$0.27 | −$0.32 | −$0.33 | −$0.37 | −$0.37 | −$1.17 | −$0.05 | −$0.42 | −$0.72 |
| EPS, diluted | $0.35 | −$0.12 | −$0.52 | −$0.27 | −$0.32 | −$0.33 | −$0.37 | −$0.37 | −$1.17 | −$0.05 | −$0.42 | −$0.72 |
| Weighted average shares, basic | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Weighted average shares, diluted | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| EBITDA | 4 | 0 | −3 | −1 | −1 | −1 | −1 | −1 | 1 | 1 | −1 | −3 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBIT | 3 | −1 | −4 | −2 | −3 | −2 | −3 | −2 | −1 | 0 | −2 | −4 |
